IP Library Assignment 032944/0517
Patent Assignment
Reel/Frame 032944/0517

Assignment of Assignor's Interest

Recorded: 2014-05-21 Pages: 3
Assignors
WRIGHT, JIM A.
Executed: 2005-10-26
YOUNG, AIPING H.
Executed: 2005-10-25
Assignee
GENESENSE TECHNOLOGIES INC.
2 MERIDIAN ROAD, TORONTO, ONTARIO, M9W 4Z7, CANADA
Covered Property (1)
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and Uses Thereof in the Treatment of Cancer
Patent: 7,968,526 →
Application: 12/691,664 →
Publication: US 2010/0197766
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 21, 2014
From: GENESENSE TECHNOLOGIES INC.
To: LORUS THERAPEUTICS INC.
Reel/Frame 032944/0520 →
Change of Name Sep 22, 2014
From: LORUS THERAPEUTICS INC.
To: APTOSE BIOSCIENCES INC.
Reel/Frame 033793/0620 →